Mesoblast (MESO) Receivables (2015 - 2026)
Mesoblast (MESO) posted Receivables of $57.66 million for the quarter ended Jun 30, 2026, up 283.0% from $15.06 million a year earlier.
Powered by 
Analysis
Mesoblast (MESO) Receivables (2015 - 2026) Analysis & Trends
Since the quarter ended Jun 30, 2015, Mesoblast has reported Receivables for 38 quarters.
- Annual Receivables shows a five-year compound annual growth rate of 64.1% (years ended Jun 2021 to Jun 2026).
- In prior years, Mesoblast's Receivables was $15.06 million in the year ended Jun 30, 2025 (-28.1%), $20.95 million in the year ended Jun 30, 2024 (+199.4%), $7 million in the year ended Jun 30, 2023 (+58.9%) and $4.4 million in the year ended Jun 30, 2022 (-9.1%).
- The figure for the quarter ended Jun 30, 2026 stands as the highest quarterly Receivables in data going back to the quarter ended Jun 30, 2015.
- The strongest year-over-year quarter for Receivables in the past five years was the quarter ended Jun 30, 2026, with growth of 283.0%; the weakest was the quarter ended Sep 30, 2022, with a decline of 31.3%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 12.74 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 14.33 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 10.35 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 14.19 Bn |
| 10 | Mesoblast | 1.84 Bn | 1.40 Bn | - | 57.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 57.66 Mn |
| Dec 31, 2025 | 43.30 Mn |
| Jun 30, 2025 | 15.06 Mn |
| Dec 31, 2024 | 3.00 Mn |
| Jun 30, 2024 | 20.95 Mn |
| Dec 31, 2023 | 4.00 Mn |
| Jun 30, 2023 | 7.00 Mn |
| Mar 31, 2023 | 8.39 Mn |
| Dec 31, 2022 | 5.12 Mn |
| Sep 30, 2022 | 3.86 Mn |
| Jun 30, 2022 | 4.40 Mn |
| Mar 31, 2022 | 5.63 Mn |
| Dec 31, 2021 | 6.05 Mn |
| Sep 30, 2021 | 5.63 Mn |
| Jun 30, 2021 | 4.84 Mn |
| Mar 31, 2021 | 2.95 Mn |
| Dec 31, 2020 | 3.34 Mn |
| Sep 30, 2020 | 2.45 Mn |
| Jun 30, 2020 | 1.57 Mn |
| Mar 31, 2020 | 3.00 Mn |
API Access
Mesoblast Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=MESO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "MESO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=MESO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();